Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).
Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cardiovascular complications in patients with post-acute sequelae of SARS-CoV-2 infection (PASC).
复制标题
关于 SARS-CoV-2 感染急性后遗症（PASC）患者心血管并发症评估和治疗的多学科协作共识指导声明。
DOI：
10.1002/pmrj.12859
复制
发表时间：
2022
期刊：
影响因子：
--
通讯作者：
Verduzco-Gutierrez
中科院分区：
文献类型：
--
作者：
Whiteson,JonathanH;Azola,Alba;Barry,JohnT;Bartels,MatthewN;Blitshteyn,Svetlana;Fleming,TalyaK;McCauley,MarkD;Neal,JacquelineD;Pillarisetti,Jayasree;Sampsel,Sarah;Silver,JulieK;Terzic,CarmenM;Tosto,Jenna;Verduzco-Gutierrez
严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）是导致2019冠状病毒病（COVID-19）的病毒，自2019年底以来在全球范围内造成了大量死亡率和发病率。SARS-CoV-2感染（PASC）的急性后后遗症可表现为一系列新的、复发的或持续的致残症状或健康问题，人们从急性感染时起就可能经历这些症状或健康问题，并在感染后持续或开始4周或更长时间。感染导致COVID-19的病毒。
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), has caused substantial mortality and morbidity worldwide since late 2019. The postacute sequelae of SARS-CoV-2 infection (PASC) can manifest as a wide range of new, recurring, or ongoing disabling symptoms or health problems that people can experience from the time of acute infection and persisting or starting 4 or more weeks after being infected with the virus that causes COVID-19.